Related Experiment Video
Updated: May 17, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
[Renal cancer biomarkers. What is justified?]
1Institut für Klinische Pathologie, UniversitätsSpital Zürich, Schmelzbergstr. 12, 8091 Zürich. holger.moch@usz.ch
Abstract:
Renal carcinoma biomarkers are of potential interest for the diagnosis of renal tumor subtypes and prediction of prognosis or reponses to targeted therapies. Due to the identification of novel renal tumor subtypes, diagnostic immunohistochemical biomarkers are of increasing importance. However, there is currently not enough clinical evidence to recommend prognostic or predictive biomarkers in routine pathology. Therapeutic decisions are still based on correct tumor classification, tumor differentiation grade, and tumor stage. Recent studies have emphasized the relevance of detailed analysis of hilus fat tissue for a correct pT-category. This review summarizes recent developments in renal cancer biomarker research.
Related Concept Videos
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Chronic Kidney Disease III: Interprofessional Care

